Related Experiment Videos
Pediatric cryptic vascular malformations: presentation, diagnosis and treatment
S F Ciricillo1, P H Cogen, M S Edwards
1Division of Pediatric Neurosurgery, University of California, San Francisco.
Pediatric Neurosurgery
|January 1, 1994
Summary
Cryptic vascular malformations (CVMs) are increasingly found in children. Surgical excision is recommended for symptomatic CVMs, with radiation therapy playing no role in treatment.
Area of Science:
- Neurology
- Pediatric Neurosurgery
- Vascular Imaging
Background:
- Cryptic vascular malformations (CVMs) are increasingly diagnosed in pediatric patients.
- The natural history and optimal treatment for CVMs remain uncertain.
- Magnetic resonance (MR) imaging has improved CVM detection.
Purpose of the Study:
- To review the presentation, diagnostic methods, treatment, and outcomes of pediatric CVMs.
- To evaluate the effectiveness of surgical intervention for CVMs.
- To clarify the role of radiation therapy in CVM management.
Main Methods:
- Retrospective review of 37 pediatric patients with CVMs treated between 1982 and 1992.
- Analysis of clinical presentation, MR imaging, angiography, surgical procedures, and patient outcomes.
- Assessment of complications and long-term follow-up.
Main Results:
- MR imaging was diagnostic in all cases; angiography was often negative.
- Surgical excision was the primary treatment, with no surgical mortality.
- One-third of patients experienced perioperative complications, mostly resolving quickly.
- Radiation-induced CVMs generally remained asymptomatic with follow-up, except for one hemorrhage case.
- Two patients with complex CVMs showed neurological decline post-surgery.
Conclusions:
- CVMs are more common in children than previously thought.
- Complete surgical excision is the recommended treatment for symptomatic CVMs presenting with seizures or hemorrhage.
- Radiation therapy is not indicated for CVMs and may contribute to their formation.
- Close clinical and radiological follow-up is essential for assessing treatment efficacy and disease progression.